Foresite Capital Management VI LLC
WEST HOLLYWOOD, CA · CIK 2013341 · 13F filing filed 2026-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
$642.6m
reported value
+39.6% vs Q1 2026
23positions
81.5%in top 10
8 new
6 added
1 reduced
2 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| CG ONCOLOGY INC CGON | $168.4m26.20% | Added +148.1k |
| ALUMIS INC ALMS | $119.5m18.60% | Unchanged |
| SEAPORT THERAPEUTICS INC SPTX | $38.7m6.02% | New |
| DENALI THERAPEUTICS INC DNLI | $35.9m5.59% | Added +186.8k |
| CELLDEX THERAPEUTICS INC NEW CLDX | $32.7m5.09% | Added +563.8k |
| AGIOS PHARMACEUTICALS INC AGIO | $29.1m4.53% | Added +260.0k |
| CORVUS PHARMACEUTICALS INC CRVS | $27.4m4.26% | Unchanged |
| PARABILIS MEDICINES INC PBLS | $27.3m4.26% | New |
| GH RESEARCH PLC GHRS | $25.3m3.93% | Added +625.0k |
| JADE BIOSCIENCES INC JBIO | $19.7m3.07% | Added +566.7k |
| HINGE HEALTH INC HNGE | $18.3m2.85% | Unchanged |
| KYMERA THERAPEUTICS INC KYMR | $16.8m2.61% | Unchanged |
| ATAIBECKLEY INC ATAI | $14.5m2.26% | Unchanged |
| VERASTEM INC VSTM | $12.0m1.87% | Unchanged |
| BEAM THERAPEUTICS INC BEAM | $11.3m1.76% | New |
| MINERVA NEUROSCIENCES INC NERV | $11.0m1.71% | Reduced -1.0k |
| ARRIVENT BIOPHARMA INC AVBP | $10.5m1.63% | New |
| AURA BIOSCIENCES INC AURA | $9.5m1.47% | New |
| CRINETICS PHARMACEUTICALS IN CRNX | $7.9m1.23% | Unchanged |
| RESEARCH ALLIANCE CORP III RACC | $3.2m0.50% | New |
| ZURA BIO LTD ZURA | $2.7m0.41% | Unchanged |
| KAILERA THERAPEUTICS INC KLRA | $826.1k0.13% | New |
| DISC MEDICINE INC IRON | $70.9k0.01% | New |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| CENTESSA PHARMACEUTICALS PLC | $54.2m1.4m shares |
| ONKURE THERAPEUTICS INC OKUR | $6.0m1.4m shares |